Publications by authors named "Andrew Perkins"

Claim this Profile
R
Reduced PI3K(p110α) induces atrial myopathy, and PI3K-related lipids are dysregulated in athletes with atrial fibrillation.
Sebastian Bass-Stringer, Bianca C Bernardo, Gunes S Yildiz, Aya Matsumoto, Helen Kiriazis, Andrew C Perkins

J Sport Health Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenic OTUD3 Mutations Predispose to Ulcerative Colitis Due to Barrier Dysfunction.
Rabina Giri, Minyi Lee, Graham W Magor, Anne-Sophie Bergot, Yaowu He, Andrew Perkins

Cell Mol Gastroenterol Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADORE: an open platform study of ruxolitinib in combination with other novel therapies in patients with myelofibrosis.
David M Ross, Florian H Heidel, Andrew Charles Perkins, Andreas Reiter, Carl Crodel

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KLF feedback loops in innate immunity.
Jessica M Salmon, Holly Adams, Graham W Magor, Andrew C Perkins

Front Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real World Management of Cytopenias and Infections in Patients With Myelofibrosis Treated With Ruxolitinib.
Liesl A Butler, Cecily Forsyth, Claire Harrison, Andrew C Perkins

EJHaem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Assessment of Transfusion Intensity in Patients With JAK Inhibitor-Naive or -Experienced Myelofibrosis Treated With Momelotinib.
Claire N Harrison, Ruben Mesa, Moshe Talpaz, Vikas Gupta, Aaron T Gerds, Andrew Perkins

Clin Lymphoma Myeloma Leuk· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of panel-based genetic sequencing for von Willebrand disease.
Radha Ramanan, Christine Van Laer, Sarissa Baert, Cyrielle Kint, Chris Van Geet, Andrew C Perkins

Res Pract Thromb Haemost· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of navitoclax to ruxolitinib for patients with myelofibrosis with progression or suboptimal response.
Naveen Pemmaraju, Tim C P Somervaille, Francesca Palandri, Claire Harrison, Rami S Komrokji, Andrew Perkins

Blood Neoplasia· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inpatient detoxification for alcohol and other drug use: qualitative study of patients' accounts of their relationships with staff.
Joanne Neale, Beth Cairns, Kevin Gardiner, Wulf Livingston, Trevor McCarthy, Andrew Perkins

Addict Sci Clin Pract· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting γ-globin gene repression by TR4.
Andrew Charles Perkins

Blood· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell transcriptomics reveals the cellular identity of a novel progenitor population crucial for murine neural tube closure.
Zihao Deng, Marina R Carpinelli, Tariq Butt, Graham W Magor, Peinan Zhao, Andrew C Perkins

Heliyon· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in linker-2 of KLF1 impair expression of membrane transporters and cytoskeletal proteins causing hemolysis.
Stephen Huang, Casie Reed, Melissa Ilsley, Graham Magor, Michael Tallack, Andrew Perkins

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variants leading to dysfibrinogenaemia in the fibrinogen α-chain at residue Arg19 are not solely associated with bleeding, but also with thrombotic events-RESPONSE.
Radha Ramanan, James D McFadyen, Andrew C Perkins, Huyen A Tran

Br J Haematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY Studies.
Stacie Hudgens, Srdan Verstovsek, Lysbeth Floden, Claire N Harrison, Jeanne Palmer, Andrew A Perkins

Value Health· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dual orexin receptor antagonist suvorexant in alcohol use disorder and comorbid insomnia: A case report.
Erin J Campbell, Yvonne Bonomo, Lisa Collins, Amanda Norman, Helen O'Neill, Andrew Perkins

Clin Case Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variability of bone marrow biopsy reporting affects accuracy of diagnosis of myeloproliferative neoplasms: data from the ALLG MPN01 registry.
Wei Yang Ng, Wendy N Erber, Andrew Grigg, Karin Dunne, Andrew Perkins

Pathology· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis.
Stephen T Oh, Srdan Verstovsek, Vikas Gupta, Uwe Platzbecker, Timothy Devos, Andrew Perkins

EJHaem· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Waiting for inpatient detoxification: A qualitative analysis of patient experiences.
Joanne Neale, Beth Cairns, Kevin Gardiner, Wulf Livingston, Trevor McCarthy, Andrew Perkins

Int J Drug Policy· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making good on the promise of genomics in healthcare: the NSW Health perspective.
Deb Willcox, Ronald J A Trent, Nigel Lyons, Cliff Meldrum, Peter Kennedy, Andrew Perkins

Aust Health Rev· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congenital fibrinogen disorders: Strengthening genotype-phenotype correlations through novel genetic diagnostic tools.
Radha Ramanan, James D McFadyen, Andrew C Perkins, Huyen A Tran

Br J Haematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New era for myelofibrosis treatment with novel agents beyond Janus kinase-inhibitor monotherapy: Focus on clinical development of BCL-X /BCL-2 inhibition with navitoclax.
Naveen Pemmaraju, Jacqueline S Garcia, Andrew Perkins, Jason G Harb, Andrew J Souers

Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM Study.
Ruben A Mesa, Claire Harrison, Jeanne M Palmer, Vikas Gupta, Donal P McLornan, Andrew Charles Perkins

Hemasphere· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study.
Aaron T Gerds, Srdan Verstovsek, Alessandro M Vannucchi, Haifa Kathrin Al-Ali, David Lavie, Andrew Perkins

Lancet Haematol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel RUNX1 Genetic Variant Identified in a Young Male with Severe Osteoporosis.
Tomasz J Block, Cat Shore-Lorenti, Roger Zebaze, Peter G Kerr, Anna Kalff, Andrew Charles Perkins

JBMR Plus· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptomatic benefit of momelotinib in patients with myelofibrosis: Results from the SIMPLIFY phase III studies.
Ruben A Mesa, Stacie Hudgens, Lysbeth Floden, Claire N Harrison, Jeanne Palmer, Andrew Perkins

Cancer Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis